Vitamins & Supplements with Ozempic

Last reviewed: May 25, 2026

Last updated: May 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 receptor agonists like Ozempic reduce appetite and slow gastric emptying, leading to lower overall caloric intake and potential micronutrient deficiencies. Research shows patients on GLP-1 therapy may experience gaps in B vitamins, iron, calcium, and protein—requiring intentional supplementation to preserve lean muscle and metabolic function.

Weight loss medications work most effectively when paired with evidence-based nutritional support. PlexusDx uses precision wellness principles to help providers assess individual nutrient vulnerability, genetic factors affecting nutrient absorption, and baseline biomarkers that guide personalized supplementation during GLP-1 treatment.

How GLP-1 Medications Alter Nutrient Absorption and Intake

GLP-1 agonists slow gastric motility and increase satiety signals, reducing food volume consumed by 30–50% in many patients. This caloric restriction, while therapeutic for weight loss, also decreases absolute nutrient intake—especially protein, iron, folate, and B12, which rely on adequate stomach acid and normal digestion timing.

Additionally, reduced food intake may lower dietary diversity, increasing reliance on supplemented vitamins. Protein deficiency during rapid weight loss accelerates muscle catabolism; clinical evidence suggests patients losing more than 1–2 pounds weekly benefit from 1.2–1.6 g/kg protein daily to preserve lean mass and metabolic rate.

Critical Micronutrient Gaps During GLP-1 Treatment

The most common deficiencies observed in GLP-1 users include B vitamins (especially B12 and folate), iron, calcium, vitamin D, and magnesium. These shortfalls emerge within 3–6 months if not addressed proactively. A baseline micronutrient panel—measuring serum B12, folate, iron stores (ferritin), 25-OH vitamin D, and magnesium—provides data-driven supplementation guidance.

Nutrient	Why GLP-1 Users Need It	Baseline Marker	Typical Supplementation Range
Vitamin B12	Reduced stomach acid and intrinsic factor; neurological risk if depleted	Serum B12 or methylmalonic acid	1,000–2,000 mcg/month injection or 2,000–5,000 mcg sublingual daily
Folate	Essential for DNA synthesis and cell division during weight loss; low intake from fewer vegetables	Serum folate or RBC folate	400–1,000 mcg daily (methylfolate preferred)
Iron	Reduced meat and fortified grain intake; slow gastric emptying reduces absorption	Serum ferritin, TIBC, transferrin saturation	18–27 mg elemental iron daily with vitamin C (avoid with calcium)
Vitamin D	Limited sun exposure and reduced dairy; supports bone density during rapid weight loss	25-OH vitamin D (ng/mL)	2,000–4,000 IU daily (target 40–60 ng/mL)
Calcium	Reduced dairy intake + vitamin D deficiency increases bone loss risk	Serum calcium, urinary calcium, DEXA if at risk	1,000–1,200 mg daily from food + supplement (separate from iron)
Magnesium	Supports muscle function and energy; depleted by rapid weight loss and GLP-1 side effects	Serum or RBC magnesium (less reliable)	300–400 mg daily (glycinate preferred for GI tolerance)

Protein and Amino Acid Strategy During Rapid Weight Loss

Protein preservation is non-negotiable during GLP-1 treatment. Aim for 30–40 grams per meal across 3 meals (90–120 grams daily minimum), sourced from whole foods where tolerated plus targeted supplements. Whey, casein, or plant-based protein powders mitigate nausea and reduce food volume while maintaining amino acid intake.

Branched-chain amino acids (BCAAs) and leucine-rich protocols may help reduce muscle loss during severe caloric restriction (>1,000 kcal/day deficit). Consider supplemental collagen peptides to support skin elasticity during rapid weight loss, though research on outcomes remains observational rather than definitive.

When to Test and How Genetics Inform Your Supplement Plan

Baseline micronutrient testing before starting GLP-1 therapy establishes individual vulnerability patterns. Patients with certain genetic variants—such as MTHFR polymorphisms affecting folate metabolism or FTO variants linked to nutrient sensing—may require higher-dose methylated forms of B vitamins and closer monitoring of satiety-driven deficiencies.

PlexusDx Precision Peptide Genetic Test reveals predispositions in nutrient absorption pathways (FTO rs9939609, for example, influences metabolic rate and appetite regulation). Pairing genetic context with baseline biomarkers allows providers to recommend personalized supplement protocols rather than generic multivitamins. Retest after 12 weeks on GLP-1 therapy to assess adequacy and adjust dosing.

Safety Considerations and Supplement–Medication Interactions

Iron and calcium supplements must be separated by 2+ hours from each other and from GLP-1 injections to avoid absorption interference. Iron is best taken on an empty stomach with vitamin C (orange juice) for enhanced absorption; calcium citrate is preferred over carbonate form in hypochlorhydric (low acid) conditions. Monitor for constipation, a common side effect amplified by supplemental iron.

Not all patients on GLP-1 require identical supplements. Vegans and vegetarians should prioritize B12, iron, and vitamin D from the outset. Patients with a history of anemia, thyroid disease, or bone loss warrant earlier and more aggressive micronutrient support. Discuss all supplements with your prescribing provider to ensure alignment with your individual health history and concurrent medications.

How PlexusDx Supports a More Personalized Approach

PlexusDx helps contextualize nutrient vulnerability by combining biomarker assessment with genetic predispositions in metabolic and appetite-regulation pathways. Your Precision Peptide Genetic Test may reveal variants affecting how your body senses satiety, processes nutrients, and responds to caloric restriction—information that can inform more targeted supplementation conversations with your provider. These genetic insights should be interpreted as predispositions affecting nutrient metabolism, not guarantees of exact supplementation needs.

The Precision Peptide Genetic Test examines variants including FTO rs9939609, which influences appetite signaling and metabolic efficiency during weight loss. Patients with specific FTO genotypes may experience faster nutrient depletion or altered satiety regulation, suggesting a need for closer monitoring of B vitamins, iron, and magnesium levels. Combined with your baseline micronutrient panel, this information helps providers design a supplement protocol tailored to your genetic context.

When you're ready to start compounded GLP-1 therapy—such as compounded semaglutide injection from $149/mo or oral semaglutide from $249/mo—sharing your genetic and biomarker data with your prescribing provider ensures supplementation is coordinated with your medication protocol. This precision approach reduces guesswork and supports sustainable, nutrient-preserved weight loss.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Vitamins & Supplements with Ozempic | PlexusDx Guide